Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Proactive news headlines: Endeavour Mining, Faron Pharma, Strategic Minerals, DiscoverIE, and more

Antipa Minerals Ltd (ASX:AZY) has reported significant zones of higher-grade gold mineralisation from within the original GEO-01 discovery samples at its flagship Minyari Dome Gold-Copper Project in Western Australia’s Paterson Province.

The GEO-01 discovery, made in August, was based on four metre composite samples, while the latest assay results revealing significantly high gold mineralisation come from one metre re-splits of the original discovery drilling assays.

Read more

Boutique investment bank Peel Hunt has lauded the preliminary clinical findings from Faron Pharmaceuticals Limited (AIM:FARN, OTC:FPHAF), terming them as 'highly encouraging.'

The data comes from an interim analysis of the BEXMAB study, a Phase I/II trial assessing the effectiveness of bexmarilimab in treating acute myeloid leukaemia (AML) and myelodysplastic syndromes (MDS), both challenging blood disorders often unresponsive to conventional therapies.

Read more

Cellular Goods PLC (LSE:CBX) shares vaulted 21% higher to 0.52p after its wholly owned subsidiary King Tide Carbon Canada formed a joint venture to "explore the untapped potential of kelp" as a tool to fight climate change and help decarbonise global supply chains.

The joint venture comes after the London-listed company acquired King Tide Carbon in May and then in July formed an agreement with Springtide Seaweed, a Maine-based kelp farming specialist.

Read more

Endeavour Mining PLC (LSE:EDV, TSX:EDV, OTCQX:EDVMF) told investors that an extensive and ongoing drill campaign at the Tanda-Iguela property in Côte d’Ivoire is confirming its potential to be the company’s “next cornerstone asset”.

Some 123,514 metres have been drilled to date at Tanda-Iguela since the start of the year, representing a major increase on the originally planned 70,000-metre campaign.

Read more

Caledonia Mining Corporation PLC (AIM:CMCL, NYSE-A:CMCL) hailed record quarterly gold production from the Blanket Mine in Zimbabwe.

In the three months ending 30 September, the mine produced 21,772 ounces of gold, up 3% on the same period a year earlier.

Read more

Mila Resources PLC (LSE:MILA) has made good progress on its joint venture with Australia-listed giant Liontown Resources (ASX:LTR) for lithium exploration at Mila’s Katleen Valley licence in Western Australia.

Mila and Liontown have held a number of meetings to establish a critical path towards commencing lithium exploration at Kathleen Valley.

Read more

Team Internet Group (AIM:TIG) has confirmed that it has now officially changed its name from CentralNic, following an announcement last month.

Having unveiled the rebrand in early September, the internet solutions group confirmed the process had now been completed on Wednesday.

Read more

Cellular Goods PLC (LSE:CBX)’ wholly owned subsidiary King Tide Carbon Canada has formed a joint venture with Springtide Seaweed to collaborate on carbon sequestration and removal services through sustainable kelp farming.

Springtide Seaweed is in the business of growing, cultivating and harvesting kelp. The group cultivates multiple species in the State of Maine, providing nursery and farm technology services to other kelp farms globally.

Read more

Faron Pharmaceuticals Limited (AIM:FARN, OTC:FPHAF)'s chief executive Dr Markku Jalkanen has described as "extremely encouraging" emerging data from the company's ongoing phase I/II trial.

Its BEXMAB study is evaluating the efficacy of bexmarilimab in treating acute myeloid leukaemia (AML) and myelodysplastic syndromes (MDS).

Read more

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK